TheEdgeResearch
Home / Stocks / BMGL

Basel Medical Group Ltd Ordinary Shares (BMGL)

NASDAQ Healthcare Medical - Care Facilities
$4.18 ▼ -16.23%
Market Cap
$6.5M
Sector
Healthcare
Industry
Medical - Care Facilities
Beta
0.24
52-Wk Range
4.17-26.4
CEO
Yen Feng Chhoa
Country
SG
Currency
USD

Basel Medical Group Ltd Ordinary Shares operates in the Medical - Care Facilities industry of the Healthcare sector, headquartered in Singapore, CE, SG. The stock last traded at $4.18, down 16.23% on the session, giving a market capitalisation of $6.5M. On trailing twelve-month figures it carries a trailing P/E of -15.28, a net margin of -67.7%. Its beta of 0.24 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-15.28
Price / Sales
0.59
Price / Book
1.33
EV / EBITDA
-10.08
Gross margin
-2.4%
Operating margin
-31.7%
Net margin
-67.7%
Return on equity
Debt / equity
1.57
Current ratio
1.88
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Global Market
Employees
70
IPO date
2025-02-25
Headquarters
Singapore, CE, SG
About Basel Medical Group Ltd Ordinary Shares

Basel Medical Group Ltd, an entity established in Singapore in 2023, is dedicated to delivering a comprehensive range of healthcare services. Its operations span multiple key areas, including specialist medical expertise, medical supplies and equipment, advanced medical technology solutions, and pharmaceutical products.

Comparable companies

Basel Medical Group Ltd Ordinary Shares is most often compared with the following Healthcare names:

IBIOINTSITRMLDDDMODDNTRBPIIIPRPORBOTTLPH
More research on BMGL
BMGL technical analysis BMGL TheEdge Score Compare against peers
Open full interactive analysis & DCF →